Why Is Small Company ShareWatch Better Than Investors Chronicle?

A detailed comparison for investors seeking UK small-cap, AIM and growth stock opportunities.

📌 Key Takeaways

Small Company ShareWatch focuses exclusively on UK small-cap and AIM-listed companies.
Investors Chronicle covers the entire investment universe, including funds, ETFs and global markets.
SCSW specialises in identifying under-researched growth opportunities before they reach the mainstream.
Investors Chronicle is better suited to investors seeking broad portfolio coverage.
SCSW provides direct management access and specialist small-cap research.

Quick Answer

Small Company ShareWatch is generally the better choice for investors looking to uncover under-researched AIM and small-cap opportunities.

Investors Chronicle is generally the better choice for investors seeking broader market coverage, portfolio management ideas and fund research.

Small Company ShareWatch vs Investors Chronicle

Feature	Small Company ShareWatch	Investors Chronicle
Primary Focus	UK Small Caps & AIM Stocks	Broad UK & Global Investing
Research Style	Direct management meetings	Desk-based fundamental analysis
Coverage	Monthly specialist publication	Weekly publication
Company Access	200+ CEO/CFO meetings annually	Primarily public filings
Best For	Small-cap stock pickers	Diversified investors

Why Small Company ShareWatch Has an Advantage

1. Focus on Under-Researched Companies

SCSW specialises in companies often ignored by institutions and mainstream analysts. This allows investors to discover opportunities before they become widely followed.

2. Direct Access to Management Teams

The publication conducts hundreds of meetings with CEOs and CFOs each year, providing insight that may not be available through company announcements alone.

3. Clear Investment Theses

SCSW focuses on identifying specific catalysts that can drive shareholder value, helping investors understand the key reasons behind each recommendation.

4. Shrinking Small-Cap Coverage from Mainstream Financial Media

It is widely recognised that mainstream financial media has steadily reduced its focus on UK small companies. The Financial Times has significantly scaled back its small-cap coverage over the years, and in 2026 Investors’ Chronicle also lost its long-standing small-cap specialist, Simon Thompson. As a result, dedicated coverage of smaller companies has become increasingly scarce, creating a gap that specialist publications like SCSW continue to fill.

Which Publication Is Right for You?

✅ Choose Small Company ShareWatch If:

You invest in UK small-cap shares.
You focus on AIM-listed growth companies.
You want under-researched opportunities.
You prefer company-specific research.
You seek higher-growth potential investments.

📈 Choose Investors Chronicle If:

You want broad market coverage.
You invest in funds and ETFs.
You follow global markets.
You value weekly updates.
You prefer diversified portfolio research.

Frequently Asked Questions

Is Small Company ShareWatch worth the subscription cost?

For investors focused on AIM and UK small-cap investing, many subscribers believe the specialist research and management access justify the cost.

Does Investors Chronicle cover small-cap stocks?

Yes, but small-cap coverage is only one part of a much broader investment offering.

Which publication is best for AIM investing?

Small Company ShareWatch is generally regarded as one of the UK's most specialised resources for AIM and micro-cap investing.

Can investors benefit from subscribing to both?

Yes. Many investors use Investors Chronicle for market context and SCSW for specialist stock ideas.

Final Verdict

If your goal is to identify under-researched AIM and micro-cap growth stocks before they become widely recognised, Small Company ShareWatch offers a more specialised approach.

If you want broader market coverage, portfolio construction ideas and investment trust research, Investors Chronicle remains an excellent all-round publication.

For dedicated UK small-cap investors, Small Company ShareWatch provides the more focused and specialised research service.